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Introduction. Laparoscopic sleeve gastrectomy (LSG) represents a valid option for morbid obesity, either as a primary or as a
staged procedure. The aim of this paper is to report the experience of a single surgeon with LSG as a standalone operation for
morbid obesity. Methods. From April 2006 to April 2011, 200 patients underwent LSG for morbid obesity. Each patient record was
registered and prospectively collected. In July 2011, a retrospective analysis was conducted. Results. Patients were 128 females and
72 males with a median age of 40.0 years. Median pre-operative BMI was 49.4kg/m2. Median follow-up was 27.2 months. Median
post-operative BMI was 30.4kg/m2. Median %excess weight loss (%EWL) was 63.6%. Median post-operative hospital stay was
4.0 days in the ﬁrst 84 cases and 3.0 days in the last 116 cases. Six major post-operative complications occurred (3%): two gastric
stump leaks (1%), three major bleedings (1.5%) and 1 (0.5%) bowel obstruction. One case of mortality was registered (0.5%). To
date only 4 patients are still in the range of morbid obesity (BMI > 35kg/m2). Conclusions. Laparoscopic sleeve gastrectomy is a
formidable operation in the short-term period. Median %EWL in this series was 63.6% at 27.2 months follow-up.
1.Introduction
Obesity is a major worldwide problem in public health,
reaching epidemic proportions in western countries.
Bariatric surgery has been shown to be more eﬀective in
the management of morbid obesity, compared to medical
treatments in terms of weight loss and amelioration of
comorbidities [1].
Laparoscopic sleeve gastrectomy (LSG) represents a valid
option for morbidly obese patients, either as a primary or
as a staged bariatric procedure. Initially, LSG was conceived
as a restrictive component of the biliopancreatic diversion
and duodenal switch. Later on, LSG has been proposed as
a step procedure in high-risk patients, followed by a second
step Roux-en-Y gastric bypass or biliopancreatic diversion
and duodenal switch [2]. Recently, LSG has been proposed
as a standalone bariatric procedure. Excess weight loss
and remission of comorbidities have been reported to take
place in a frequency comparable with other well-established
procedures [3].
The experience at our institution with LSG as a primary
operation for morbid obesity started in 2006. The aim of this
work is to report the ﬁve-year experience of a single surgeon
singlecenterwithLSGasasoleoperationformorbidobesity.
2. Methods
At our Institution, the bariatric surgery program started
in 1996, with a laparoscopic gastric banding. After a 10-
year experience with laparoscopic Roux-en-Y gastric bypass,
gastric banding, biliopancreatic diversion with duodenal
switch, and several bariatric reoperations, the ﬁrst LSG was
performed in April 2006. From April 2006 to April 2011, 200
patients were submitted to LSG as a primary procedure for
morbid obesity.
Patients were studied preoperatively with a multi-
disciplinary workup including specialistic counseling
(surgery, endocrinology, internal medicine, psychiatry,
anesthesiology), gastrointestinal endoscopy, and complete
performance status evaluation. Patients were well informed
about the surgical procedure, with all potential advantages
and possible complications and side eﬀects. Indications
for LSG were the following conditions: BMI over 60kg/m22 Gastroenterology Research and Practice
in high-risk patients, BMI between 50 and 60kg/m2 in
nondiabetic patients, BMI between 40 and 50kg/m2 in
patients refusing a complex procedure like Roux-en-Y
gastric bypass, patients with severe gastric inﬂammatory
disease and H. pylori infection, patients with previous
abdominal surgery involving the intestines, and young
patients refusing gastric banding. Diabetic patients were ﬁrst
selected for Roux-en-Y gastric bypass and then to LSG if
they refused the gastric bypass. Speciﬁc contra-indications,
apart from the general contraindications to bariatric surgery,
were severe and documented gastroesophageal reﬂux disease
and previous gastric surgery.
Standardsurgicaltechnique(Figure 1)wasasfollows:the
patientwasplacedinasupinepositionontheoperatingtable
w i t hh i sa r m se x t e n d e di na b d u c t i o na n dl e g so p e n e d ,i n
reverse Trendelenburg position with a 10◦ tilt. The surgeon
stood between the legs with the assistant on the left side
of the patient, and the cameraperson to the patient’s right.
Abdominal insuﬄation was set at 15mmHg. Trocars were
placed as follows: a 10mm trocar (T1) 20cm below the
xiphoid process for the 30◦ optical system, a 5mm trocar
(T2) on the left anterior axillary line, a 12mm trocar
(T3) on the left mid-clavicular line just between the ﬁrst
and the second trocars, a 12mm trocar (T4) on the right
midclavicularline,anda5mmtrocar(T5)belowthexiphoid
process. Using a dissecting coagulator (Ultracision, Ethicon
Endo-Surgery), the greater curvature of the stomach was
mobilized at a point 3cm proximal to the pylorus. The
lesser sac was entered, and staying close to the wall of the
stomach, the greater curvature ligaments (gastrosplenic and
gastrocolic) were divided all the way up to the angle of His.
We paid particular attention to the identiﬁcation and
mobilizationoftheangleofHiswithexposureoftheleftcrus
of the diaphragm to delineate the gastroesophageal junction
and to facilitate complete resection of the gastric fundus.
Retrogastric adhesions were taken down with the Ultracision
device to allow for complete mobilization of the stomach, to
eliminate any redundant posterior wall of the sleeve, and to
exclude the fundus from the gastric sleeve.
After a complete mobilization of the stomach was
reached, a 40 Fr orogastric tube was inserted transorally into
the pylorus and placed against the lesser curvature. This
helped to calibrate the size of the gastric sleeve, prevent any
constriction at the gastroesophageal junction, and provide a
uniform shape to the entire stomach.
Gastric transection by a cutting stapler (recently, a
Echelon Flex, Ethicon Endo-Surgery) began at a point 3cm
proximal to the pylorus, leaving the antrum and preserving
gastric emptying. The stapler was ﬁred consecutively along
the length of the orogastric tube until the angle of His was
reached. Care was taken not to narrow the stomach at the
angularis. We considered important to inspect the stomach
anteriorly and posteriorly to ensure no redundant posterior
stomach.
The entire staple line was inspected for bleeding and
testedforleak.Thepatientwasplacedﬂat,andanatraumatic
clampwasplacednearthepylorus.Theintegrity ofthestaple
line was tested by insuﬄating air under saline and infusing
30–60cm3 of methylene blue into the remaining stomach.
Figure 1: Surgical technique of sleeve gastrectomy.
Staple line reinforcement was performed using various
techniques: (1) the stapler was supported by the application
of the Gore Seamguard (W. L. Gore & Associates, Flagstaﬀ,
AZ, USA) before the introduction of the device in the
abdomen; (2) the staple line was reinforced by seroserosal
running sutures using absorbable material from the last
ﬁring of the stapler towards the ﬁrst one; (3) the entire
staple line was covered by Floseal, a thrombin gelatin matrix,
gently squeezed over the entire staple line. The resected
stomach was extracted through the periumbilical incision
at the end of the procedure. At the beginning of the
experience a nasogastric tube and a suction drain were left
in place; recently, no drains and nasogastric tube were used.
The fascial defects were closed with a ﬁgure of eight 2/0
nonabsorbable suture to prevent port site hernia.
A gastrograﬁn swallow test was performed on the ﬁrst
postoperative day (Figure 2), and a liquid diet was started.
Patients were discharged from the hospital as soon as they
could walk, drink, with no fever or any clinical complication.
Patients were given a liquid diet for two weeks and followed
up in our outpatient clinic for years. Followup was per-
formed by an endocrinologist, a nutrition expert, surgeon,
and psychiatrist. The frequency of each outpatient visit was
every three months for the ﬁrst year and every six months for
the following years.
Each patient record was registered by the surgical team
and prospectively collected. In July 2011, a retrospective
analysis was conducted and results are hereby presented.
3. Results
From April 2006 to April 2011, 200 patients underwent
a laparoscopic sleeve gastrectomy as a primary operation
for morbid obesity. They were 128 females and 72 males
with a median age of 40.0 years (range from 16 to 64Gastroenterology Research and Practice 3
Figure 2: Postoperative swallow test.
years). Median preoperative BMI was 49.4kg/m2 (range
from 40 to 78kg/m2). Median followup was 27.2 months
(range from 3 to 63 months). Followup last update was
performed successfully in all patients, in 182 cases with
a hospital visit and in 17 cases by phone (1 patient died
postoperatively). Median postoperative BMI at last followup
visit was 30.4kg/m2 (range from 25 to 37kg/m2). Median %
excess weight loss (% EWL) at last followup visit was 63.6%.
Median postoperative hospital stay was 4.0 days (range
from 3 to 62 days) in the ﬁrst 84 cases and 3.0 days (range
from 3 to 28 days) in the last 116 cases. This result was
achieved with a new protocol involving prehospitalization,
admission on the day of surgery, and early discharge. Median
o p e r a t i v et i m ew a s1 0 2m i n u t e s( r a n g ef r o m6 4t o1 8 0
minutes). Conversion to open surgery was required in 2
cases (1%) for diﬃcult dissection in 2 patients with previous
abdominal surgery.
Six major postoperative complications were observed
(3%). Two gastric stump leaks (1%), three major bleedings
(1.5%), and 1 (0.5%) small bowel obstruction occurred.
The two gastric leaks occurred both at the gastroesophageal
junction. One case of mortality was registered on the 62nd
postoperative day (0.5%).
Theﬁrstleakwasina16-year-oldgirlwithapreoperative
BMI of 68kg/m2 submitted to LSG in April 2009. Staple-
linereinforcementwasperformedwiththethrombinmatrix.
After an uneventful procedure and a regular postoperative
course, the patient was discharged on the 5th postoperative
day. She was readmitted on the 9th postoperative day with
abdominal pain and fever. CT scan with a gastrograﬁn
swallow revealed a small leak from the gastric stump
immediately below the gastroesophageal junction. She was
treated with relaparoscopy, drainage, and total parenteral
nutrition. A new swallow two weeks later showed complete
healingofthegastricﬁstula,andoralfeedingwasstarted.She
is doing ﬁne at two-year followup.
T h es e c o n dl e a ko c c u r r e di na5 2 - y e a r - o l dm a nw i t h
ap r e o p e r a t i v eB M Io f5 8 k g / m 2. He underwent a LSG
with a staple line reinforcement performed with a running
suture. The patient had severe comorbidities including type
II diabetes, sleep apnea, hypertension, and mild renal failure.
He was discharged on the 5th postoperative day on a liquid
diet after a regular swallow test. He was readmitted on
the 8th postoperative day with abdominal pain, fever, and
renal failure. CT scan with a gastrograﬁn swallow showed
a large (approximately 1.5cm) gastric stump leak at the
gastroesophageal junction with peritonitis. He underwent
relaparoscopy, suture of the defect, drainage, and total
parenteral nutrition. Unfortunately his postoperative course
was complicated by renal failure and bilateral pneumonia
requiring intensive care stay. Although a CT scan revealed
no further abdominal complications, the patient died on
the 62nd postoperative day. At autopsy, a severe bilateral
pneumonia was diagnosed with no abdominal infection.
Three cases of major bleeding occurred (1.5%), two
from the staple line and one from the trocar site. The two
cases of bleeding from the staple line were observed after
reinforcement performed in the ﬁrst case with a running
suture and in the second case with Seamguard. They were
treated with laparoscopic exploration and suture of the
bleeding vessels. The patient with bleeding from the trocar
woundwasalsotreatedbylaparoscopicexplorationandopen
suture of the left epigastric artery. One blood transfusion
was required in the last patient. One small bowel obstruction
occurred in a patient submitted to LSG and discharged on
the 3rd postoperative day. She underwent a laparotomy in
another hospital, and surgeons found an acute hernia from a
trocar incision with small bowel obstruction.
With a median followup of 27.2 months, a median post-
operative BMI of 30.4kg/m2 was registered. Apart from 12
patients who have a short followup (less than 6 months),
to date, only 4 patients are still in the range of morbid
obesity (BMI > 35kg/m2). Comorbidity resolution and
improvement were seen in type II diabetes, hypertension,
and obstructive sleep apnea (Table 1).
4. Discussion
Bariatric surgery is the only evidence-based approach to
sustainable weight loss, improving comorbid disease and
survival in morbidly obese patients.
Laparoscopic sleeve gastrectomy is a formidable oper-
ation in terms of weight loss in the short and mid-
term period (5 years). As a two-stage procedure, LSG was
initially performed using a 60-French bougie with a 33%
excess weight loss at 11 months [4]. Since then surgeons
began using LSG as a primary procedure using smaller-
sized bougies with greater % EWL (62%) [5]. In a recent
systematic review, weight loss ranged from 33 to 85%
of excess weight in patients submitted to LSG [6]. The
durability of LSG at 5 years has been clearly demonstrated
[7]. Mean % EWL in this series was 64.4% at 28.2-month
followup. Clinical long-term results of LSG will emerge in
the future when most of the authors report their experience
with primary LSG over a period superior to 10 years. To
d a t e ,w em u s tc o n c l u d et h a tL S Gi sa ne x c e l l e n tw e i g h tl o s s
operation in the short and mid-term period. In addition,
LSG seems to have the potential to be an eﬀective standalone4 Gastroenterology Research and Practice
Table 1: Comorbidity resolution.
Comorbidity Improved Resolved
(1) Diabetes (n = 8; 4%) 1 (12.5%) 7 (87.5%)
(2) Hypertension (n = 98; 49%) 26 (26.5%) 72 (73.5%)
(3) Obstructive sleep apnea 12 (18.7%) 52 (81.3%)
(n = 64; 32%)
procedure for durable weight loss and comorbid resolution.
Doubts still exist regarding weight regain or the desire for
further weight loss in the superobese patients requiring the
addition of a gastric bypass or biliopancreatic diversion
to LSG. Furthermore, there is continued disagreement as
to whether LSG represents a restrictive procedure versus a
combination restrictive/hormonal procedure. Studies have
shown the eﬀects of LSG on ghrelin levels and hunger [8],
as well as additional metabolic hormones [9].
Laparoscopic sleeve gastrectomy seems to oﬀer certain
advantages compared to well-established procedures like
gastricbanding,Roux-en-Ygastricbypass,orbiliopancreatic
diversion:lackofanintestinalanastomosis,normalintestinal
absorption, no risk of internal hernias, no implantation
of a foreign body, pylorus preservation with no dumping
syndrome, continuity of gastrointestinal continuity with the
possibility to explore the entire gastrointestinal tract. Main
concerns of LSG remain unclear and need further investiga-
tion, like the risk of important postoperative complications
including staple-line leak (1–3%) and postoperative hemor-
rhage (3.5%).
In this series in 200 consecutive cases, 6 major com-
plications occurred (3%). Of the two gastric stump leaks,
one was diagnosed two weeks after the operation and was
successfully managed by laparoscopic drainage and total
parenteral nutrition with complete healing of the gastric
ﬁstula. The patient is doing well at two-year followup.
Unfortunately, the other patient with a greater leak died two
months after the operation.
Some considerations must be done about this case. He
was a high-risk patient with a BMI of 58kg/m2 with severe
comorbidities. Gastric leak probably occurred one week
after the operation and was treated by reoperation with
laparoscopic suture and drainage. At necropsy, no gastric
ﬁstula or peritonitis was diagnosed and the patient died of
bilateral pneumonia and renal failure.
A mortality rate of 0.5% in a high-risk group of patients
is acceptable, nevertheless the treatment of gastric leaks after
sleeve gastrectomy needs further investigation. To date, most
of the authors believe that the gold standard approach for
early gastric leaks is percutaneous drainage, total parenteral
nutrition, antibiotic therapy, and observation [10]. When
gastric ﬁstula occurs in the 1st or 2nd postoperative day a
laparoscopic approach with direct suture is justiﬁed and has
potentialadvantages.Inthetwocasespresentedinthisseries,
both leaks occurred in the second postoperative week and
were treated by laparoscopic exploration and drainage, with
suture of the defect in the second case.
In conclusion, LSG is a safe and eﬀective primary
treatment for morbid obesity at mid-term followup. In
the present single surgeon single center experience, LSG is
associated with excellent weight loss results with a median
followup of 27.2 months in a various population of morbidly
obese patients. Long-term studies are necessary in order to
assess the exact role of sleeve gastrectomy in the world of
bariatric surgery.
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